Nebulization inhalation is a direct drug delivery method that targets the respiratory tract and lungs, with advantages such as fast onset, high local drug concentration, and no need for deliberate patient cooperation. The general dosage of nebulized inhalation therapy is only one tenth of the total body dosage, making it very convenient to use and has become an important treatment method for respiratory system related diseases. In the treatment equipment of the Intensive Care Unit (ICU), nebulizers play a special role.
The basic principle of ICU Nebulizer is to spray out the medication for treating respiratory diseases in an aerosol form, inhale it through the patient's respiratory tract, inhale deeply with force, and use the method of oral inhalation and nasal exhalation to inhale the medication into the respiratory tract, distribute it in the trachea, bronchi, bronchioles, and alveoli, thereby achieving the treatment of respiratory infections, eliminating inflammation, reducing respiratory mucosal edema, diluting carbon fluid, and dispelling doubts. In addition, for patients with bronchoconstriction and asthma, nebulization can also be used to maintain airway patency. Secondly, for patients after tracheotomy, nebulization can keep the respiratory tract moist and prevent airway blockage due to viscous fluid. At the same time, for patients after chest surgery, nebulization can prevent infection, and is widely used in internal medicine, pediatrics, otolaryngology, obstetrics and gynecology Surgery (perioperative airway management), etc.
However, different nebulizers also have different effects in terms of use. The higher the nebulization working pressure, the deeper the nebulization drug can enter the trachea. The smaller the nebulization particles, the more they can enter the surrounding tissues. The faster the flow rate, the more sediment is deposited in the mouth and throat. The deposition in the airway and lungs is related to the machine flow rate and the suction airflow speed. The diameter of the nebulized particles is 1-5 μ m. The sinking site is in the bronchioles and alveoli; Diameter 5-20 μ m. Deposited in the bronchi; 20~40 μ m. Deposited in the nose, throat, and upper trachea. So choosing the right ICU nebulizer is particularly important.
In the selection of ICU nebulizers, many medical institutions have chosen the feellife brand. Its AirICU products can be used in hospital intensive care units (ICUs) or hospital wards with hospital ventilators, and can also be used for inhalation treatment of nebulized inhalation drugs under the guidance of community healthcare personnel. After the doctor's prescription is issued, medical staff can conveniently and quickly complete the addition of medication, enabling patients to quickly initiate nebulization inhalation therapy. It has two nebulization modes, continuous nebulization mode and respiratory induction nebulization mode, providing comfortable nebulization for direct treatment, automatically adjusting nebulization frequency, and improving drug intake opportunities. Equipped with a respiratory sensing module, it reduces waste of medication during exhalation, improves drug delivery efficiency, adopts industry-leading mesh nebulization technology, and outputs aerosols with high FPF (fine particle ratio), which is conducive to drug deposition in patients' lungs and improves clinical treatment effectiveness. This device can be used as a nebulized vaccine vaccination device to help medical staff complete nebulized vaccine vaccination for the public. It can achieve triple immunity of mucosa, body fluid, and cells, improve vaccine coverage rate, promote vaccine accessibility, and also obtain international CE certification.
Feellife's AirICU is suitable for the use of various drugs, such as glucocorticoids, bronchodilators, antibiotics, expectorants, etc. nebulized inhalation directly reaches the target tissue, achieving a 'precise strike'. Generally speaking, oral administration requires passing through the digestive and circulatory systems before reaching the respiratory system. Injected medication passes through the circulatory system and reaches the respiratory system. Compared to oral and intravenous administration, inhalation therapy directly affects the lungs and has the advantages of rapid onset, good efficacy, and good safety. It provides a fast, safe, and effective drug delivery mode in the ICU environment.
Of course, some preventive measures should be taken in clinical work to ensure the safety of ICU nebulization treatment. For example, the nebulization time should not be too long, usually around 15 minutes. If the nebulization time is too long, it can easily lead to poor triggering of the patient, insufficient ventilation, and exacerbation of breathing difficulties; Appropriate sterilization measures shall be taken for reusable spray; If the ventilator parameters are adjusted during nebulization, the settings should be reset after completion. Finally, measures should be taken to prevent the discharge of infectious aerosols.
As the leader of global nebulization brands, Feellife is quiet, efficient, and easy to install pipelines, earning the trust of world leading ICU medical staff, ensuring complete and effective control of aerosol drug delivery. Suitable for full treatment of patients, saving patient costs, increasing hospitalization turnover rate, and providing exclusive solutions for general departments, family doctors, social health, and intensive care units. It is the preferred partner for hospitals, vaccine research and development enterprises, ventilator manufacturers, research institutions, and pharmaceutical factories.